Details
Stereochemistry | RACEMIC |
Molecular Formula | C16H15Cl2N |
Molecular Weight | 292.203 |
Optical Activity | ( + / - ) |
Defined Stereocenters | 2 / 2 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
CN[C@@H]1C[C@H](C2=CC=CC=C12)C3=CC=C(Cl)C(Cl)=C3
InChI
InChIKey=SVFXPTLYMIXFRX-XJKSGUPXSA-N
InChI=1S/C16H15Cl2N/c1-19-16-9-13(11-4-2-3-5-12(11)16)10-6-7-14(17)15(18)8-10/h2-8,13,16,19H,9H2,1H3/t13-,16+/m0/s1
Indatraline (Lu 19-005) is a non-selective monoamine transporter inhibitor that has been shown to block the reuptake of dopamine, norepinephrine, and serotonin with effects similar to those of cocaine. In vivo, indatraline produced behavioral effects suggestive of enhanced dopaminergic, noradrenergic, and serotonergic activity in mice. Indatraline also substituted for a high dose of cocaine in rats trained to discriminate between a low and a high dose of cocaine, which demonstrates that indatraline produces cocaine-like discriminative stimulus effects. Indatraline has been studied to block the action of methamphetamine and MDMA.
Approval Year
Targets
Primary Target | Pharmacology | Condition | Potency |
---|---|---|---|
Target ID: CHEMBL238 Sources: https://www.ncbi.nlm.nih.gov/pubmed/11150168 |
290.0 nM [Ki] | ||
Target ID: CHEMBL228 Sources: https://www.ncbi.nlm.nih.gov/pubmed/11150168 |
38.0 nM [Ki] | ||
Target ID: CHEMBL222 Sources: https://www.ncbi.nlm.nih.gov/pubmed/11150168 |
600.0 nM [Ki] |
PubMed
Title | Date | PubMed |
---|---|---|
Pharmacology in vivo of the phenylindan derivative, Lu 19-005, a new potent inhibitor of dopamine, noradrenaline and 5-hydroxytryptamine uptake in rat brain. | 1985 Apr |
|
Effects of the long-acting monoamine reuptake inhibitor indatraline on cocaine self-administration in rhesus monkeys. | 1999 Oct |
|
Effects of indatraline and buprenorphine on self-administration of speedball combinations of cocaine and heroin by rhesus monkeys. | 2001 Jul |
|
Rhesus monkey trace amine-associated receptor 1 signaling: enhancement by monoamine transporters and attenuation by the D2 autoreceptor in vitro. | 2007 Apr |
Patents
Sample Use Guides
In Vivo Use Guide
Sources: https://www.ncbi.nlm.nih.gov/pubmed/10490887
rhesus monkeys: 0.1–0.56 mg/kg/day
Route of Administration:
Oral
Name | Type | Language | ||
---|---|---|---|---|
|
Official Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English |
Classification Tree | Code System | Code | ||
---|---|---|---|---|
|
NCI_THESAURUS |
C94725
Created by
admin on Sat Dec 16 15:51:09 GMT 2023 , Edited by admin on Sat Dec 16 15:51:09 GMT 2023
|
||
|
NCI_THESAURUS |
C265
Created by
admin on Sat Dec 16 15:51:09 GMT 2023 , Edited by admin on Sat Dec 16 15:51:09 GMT 2023
|
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
SUB08170MIG
Created by
admin on Sat Dec 16 15:51:09 GMT 2023 , Edited by admin on Sat Dec 16 15:51:09 GMT 2023
|
PRIMARY | |||
|
100000083389
Created by
admin on Sat Dec 16 15:51:09 GMT 2023 , Edited by admin on Sat Dec 16 15:51:09 GMT 2023
|
PRIMARY | |||
|
DTXSID4043981
Created by
admin on Sat Dec 16 15:51:09 GMT 2023 , Edited by admin on Sat Dec 16 15:51:09 GMT 2023
|
PRIMARY | |||
|
126280
Created by
admin on Sat Dec 16 15:51:09 GMT 2023 , Edited by admin on Sat Dec 16 15:51:09 GMT 2023
|
PRIMARY | |||
|
INDATRALINE
Created by
admin on Sat Dec 16 15:51:09 GMT 2023 , Edited by admin on Sat Dec 16 15:51:09 GMT 2023
|
PRIMARY | |||
|
86939-10-8
Created by
admin on Sat Dec 16 15:51:09 GMT 2023 , Edited by admin on Sat Dec 16 15:51:09 GMT 2023
|
PRIMARY | |||
|
4U40Y96J1Z
Created by
admin on Sat Dec 16 15:51:09 GMT 2023 , Edited by admin on Sat Dec 16 15:51:09 GMT 2023
|
PRIMARY | |||
|
C83797
Created by
admin on Sat Dec 16 15:51:09 GMT 2023 , Edited by admin on Sat Dec 16 15:51:09 GMT 2023
|
PRIMARY | |||
|
5770
Created by
admin on Sat Dec 16 15:51:09 GMT 2023 , Edited by admin on Sat Dec 16 15:51:09 GMT 2023
|
PRIMARY | |||
|
C418119
Created by
admin on Sat Dec 16 15:51:09 GMT 2023 , Edited by admin on Sat Dec 16 15:51:09 GMT 2023
|
PRIMARY | |||
|
CHEMBL296602
Created by
admin on Sat Dec 16 15:51:09 GMT 2023 , Edited by admin on Sat Dec 16 15:51:09 GMT 2023
|
PRIMARY |
ACTIVE MOIETY